Is your early-stage medtech company looking to meet high-quality investors or strategic partners? Our Innovation Summit San Francisco 2017 stage is your ideal chance to impress. Timeslots will sell out quickly – apply today!
3R Cardio (Three River Cardiovascular; Toronto, Ontario, Canada) – Our proprietary TAVR SmartGuidewire™ equips cardiologists with real-time high quality data about valve function for optimal valve placement during transcatheter aortic valve replacements (TAVR), improving patient outcomes and creating significant healthcare savings.
4C Medical Technologies (Brooklyn Park, MN) is focused on minimally invasive therapies for structural heart disease, specifically mitral valve regurgitation.
Avalun’s (Grenoble, France) LabPad® is an innovative medical device designed to meet the markets’ increasing need for multi-measurement capabilities using POC testing.
Calcivis (Edinburgh, United Kingdom) is applying biotechnology to revolutionise the management of dental caries and erosion. Its technology utilises a unique, proprietary bioluminescence approach combined with a specialised imaging device to generate images of active, ongoing demineralisation that are used to develop preventive treatment plans for patients in line with dental best practice.
Cardiac Insight (Kirkland, WA) has received FDA clearance and just begun marketing a low cost 7-day disposable ECG sensor, Cardea SOLO, into the US cardiac market. This is a game changing technology that allows for immediate diagnosis of atrial fibrillation and other cardiac anomalies using our outpatient, reimbursed device.
Carmell Therapeutics (Pittsburgh, PA) has created a unique and highly innovative patented technology based on biologically-active materials manufactured from human blood plasma. Our proprietary process binds and cross-links lyophilized plasma into solid and semi-solid plasma-based materials. These Plasma-based Bioactive Materials (PBMs) contain highly concentrated natural regenerative factors that promote healing in various clinical settings, reduce infections, and, as a result, lower healthcare costs.
Catheter Precision, Inc. (Ledgewood, NJ) is dedicated to meeting the needs of patients, hospitals and physicians in the field of cardiac electrophysiology. Our innovative product line includes forward thinking mapping and robotic systems that save time and money while preserving safety of the patient and physician.
Consensus Orthopedics (El Dorado Hills, CA) – The TracPatch wearable device is a remote monitoring system which tracks a user’s daily activities. The device has been designed as a passive and continuous data collection system with advanced learning algorithms and haptic feedback technology. TracPatch is a cross industry device designed for multiple applications. For the first-time, healthcare providers can send patients home and maintain the critical connection needed for an efficient, cost effective recovery process, improved outcomes and patient satisfaction.
Eliaz Therapeutics (Santa Rosa, CA) is developing a novel, patented and selective medical device for Chronic Kidney Disease (CKD), which is highly prevalent and progressive with significant morbidity and mortality, and currently no treatment to reverse the course of the disease is in the market. ET’s non-invasive treatment selectively removes Galectin-3 which is strongly associated with progression of CKD, and has been recognised as a contributing factor in a wide range of chronic diseases.
EndoShape’s (Boulder, CO) mission is to commercialize novel medical devices based on its proprietary polymer technology. EndoShape is focused on the coil embolization & occlusion market. EndoShape is marketing the Medusa® MultiCoil which is FDA 510(k)-cleared for sale in the United States.
Evoke Medical (Thornton, CO) is creating the next generation of biomechanically activated smart spinal implants in order to improve fusion outcomes and reduce healthcare costs.
Gauss Surgical (Los Altos, CA) has developed Triton, a cloud-connected, FDA-cleared, iPad application that accurately monitors surgical blood loss, helping to avoid delayed recognition of hemorrhage or unnecessary blood transfusion. Triton analyzes images of surgical sponges and suction canisters and assesses their Hemoglobin content using computer vision and machine learning algorithms, while integrating seamlessly into the workflow of the operating room.
Gel-e Inc. (College Park, MD) is developing a novel line of hemostatic products. With an initial focus on external wounds, gel-e combines the use of safe, inert ingredients with proprietary chemistry that has been designed for use across a broad spectrum of clinical applications, including vascular closure and during surgery.
Glucorec’s (Mountain View, CA) patented Non-Invasive Glucose Sensing technology, the personal portable device, GluFit™, is validated in preclinical human trials.
Hemovent GmbH (Aachen, Germany) is an emerging medical device company that has developed disruptive technology: the world’s smallest and first self-contained fully portable Extra Corporeal Membrane Oxygenation (ECMO) system that supports or replaces heart and lung function in the event of cardiac and respiratory failure.
Jan Medical (Mountain View, CA) is a device startup with transformative diagnostic technology in the areas of concussion and stroke.
MAG Optics (Chicago, IL) is an early-stage ophthalmic device company developing patent-pending devices relating to human vision, specifically corneal inlays. Our technology is addressing one of the largest unmet needs in ophthalmology – presbyopia (loss of near focus) and broader refractive errors.
Metamason Inc. (Los Angeles, CA) has developed a platform that unites Computer Vision, Digital Engineering, Algorithmic Design and Additive Manufacturing to create products that perfectly fit each individual for whom they are intended. The company’s flagship product is Miia™ 3D printed mask that is used for the treatment of Obstructive Sleep Apnea (OSA). Metamason’s Scan Fit Print platform™ utilizes a simple tablet that is configured with a 3D scanner. The platform employs proprietary landmark detection software and dynamic design algorithms to create a custom digital file of a patient’s facial image, the file is then transferred to our 3D print manufacturer who generates the customized mask.
MiNDERA is a SF Bay area VC-backed medtech company developing non-invasive, high precision genomic tools for skin diseases (oncology, inflammatory diseases).
Neural Analytics (Los Angeles, CA) is developing an AI-driven, robotics-enabled ultrasound technology capable of diagnosing and tracking brain health conditions, including stroke, dementia, and migraine.
Newronika srl (Milan, Italy) – Developing an implantable programmable medical device for bio-recording and deep brain stimulation (DBS) in a closed-loop, overcoming the current limitations of DBS due to the delivery of stimulation with constant parameters. Adaptive DBS (aDBS) implements a closed-loop deep brain stimulation (DBS) that adapts the stimulation in real time to follow the patient’s clinical condition by measuring the bioelectrical neuronal activity in the brain areas where the DBS electrodes are implanted. Newronika’s long term vision is to develop an expertise in building brain computers by developing new algorithms based on the recorded biosignals.
PhotoniCare (Champaign, IL) is developing an imaging platform to empower better decisions at the front lines of medicine, where treatment decisions make the largest impact on health outcomes.
Physcient’s (Durham, NC) new Differential Dissection technology enables faster, easier, and safer surgeries. Our instruments are hand-held, single-use, and in clinic now, yielding outstanding results and first sales.
Prenosis (Champaign, IL) – Technology description coming soon
Promaxo (Rockville, MD) is a medical device company developing and commercializing an office-based and cost effective MRI with cellular level spatial resolution, real time biopsy and treatment tools, and automated software for tissue characterization. The Company’s current focus is on addressing the needs of the prostate cancer market.
ProVerum Medical (Dublin, Ireland) – Technology description coming soon
Sana Health (Mill Valley, CA) provides sleep on demand to solve anxiety-related insomnia, with a biofeedback-driven neuromodulation wearable that increases neuro-plasticity for a wide range of applications starting with sleep.
Smart Medical Devices (Las Vegas, NV) – SMARTdrillTM technology allows the surgeon to drill with three-dimensional awareness. Instantaneous continuous outputs of bone density, drilling depth, drilling energy and potential construct strength prevents plunging, misdirection, thermal injury and enables the surgeon to pick the correct implant the first time, every time.
Spatial Surgical (Shrewsbury, MA) is eliminating the archaic hand tools used in orthopedic surgery with a novel all-tissue laser system that dramatically enhances surgical speed, precision, and patient outcomes.
Spectrum Dynamics Medical (Palo Alto, CA) – Technology description coming soon
StimGuard (Ft. Lauderdale, FL) is premiering the world’s first and only fully programmable, microsize office based wireless platform for control of incontinence, the CAN-Stim Tibial Nerve Stimuator the StimGuard Sacral Nerve Stimulator.
Stroma Medical Corporation (Laguna Beach, CA) is a medical device company has designed, developed and patented a proprietary laser based system that provides a non-surgically invasive treatment to change eye color in a procedure that takes roughly 30 seconds per eye to perform. The system features an eye mapping, eye tracking and a laser, driven by software to provide an adaptable, and predictable option for patients who wish to change the eye color.
Texalign (Madrid, Spain) – Wearable 3D torso imaging with millimeter accuracy, via machine intelligence and sensorized tight-fitting undergarments suitable for continuous daily wear.
Theradep Technologies (Palo Alto, CA) – Technology description coming soon
Urotronic, Inc. (Minneapolis, MN) was founded in December 2014 to research, develop and commercialize a proprietary drug coated balloon that will transform the urinary tract stricture and benign prostate hyperplasia (BPH) market through better patient outcomes and in-office ease of use uniquely positioned for today’s healthcare environment.